US Draft Bill Highlights Perceived China Biotech Threat

WuXi Scrambles To Avoid TikTok Moment

A draft bill from the US House related to national security issues sent WuXi Biologics' shares tumbling over concerns around increased US scrutiny of Chinese firms, which a company clarification did little to dispel.  

WuXi Biologics scrambles to clarify as US scrutiny over China increases • Source: Shutterstock

The US House Select Committee on the Chinese Communist Party, led by Republican lawmaker Mike Gallagher, has proposed a draft bill, BIOSECURE, unveiled on 25 January and aimed at curbing the sharing of genetic information with China's largest genomics firm BGI and its subsidiaries.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Focus On Asia